Security · CUSIP 09061GAE1
BIOMARIN PHARMACEUTICAL INC
NOTE 0.750%10/1 · institutional ownership from 13F filings
13F holders
11
Shares held
12.5M
Value held
$13.5M
New / sold out
1 / 1
Added / reduced
0 / 0
net +223.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2017
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| STATE STREET CORP | 11,480,000 | $12.4M | 0.00% |
| Bank of New York Mellon Corp | 657,000 | $716.0K | 0.00% |
| STIFEL FINANCIAL CORP | 254,000 | $277.0K | 0.00% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 76,000 | $85.0K | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC. | 21,000 | $23.0K | 0.00% |
| Veritable, L.P. | 10,000 | $11.0K | 0.00% |
| BB&T SECURITIES, LLC | 11,000 | $11.0K | 0.00% |
| Cribstone Capital Management, LLC | 5,000 | $5.0K | 0.00% |
| Mascoma Wealth Management LLC | 3,000 | $3.0K | 0.00% |
| North Star Investment Management Corp. | 2,000 | $2.0K | 0.00% |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| STIFEL FINANCIAL CORP | New | +254,000 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Sun Life Financial INC | Sold out | -31,000 | -100.0% |